Safety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial

BACKGROUND AND PURPOSE: The neuroregenerative drug Cerebrolysin has demonstrated efficacy in improving cognition in adults with stroke and Alzheimer's disease. The aim of this study was to determine the efficacy and safety of Cerebrolysin in the treatment of communication defects in infants wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanein, Sahar M.A., Deifalla, Shaymaa M., El-Houssinie, Moustafa, Mokbel, Somaia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712290/
https://www.ncbi.nlm.nih.gov/pubmed/26365023
http://dx.doi.org/10.3988/jcn.2016.12.1.79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712290/
https://www.ncbi.nlm.nih.gov/pubmed/26365023
http://dx.doi.org/10.3988/jcn.2016.12.1.79

Ejemplares similares